Increased nutritional risk is frequently found among hospitalized or institutionalized patients. 1, 2 Prevalence of increased nutritional risk varies from 20% to 30% in large case registries, to significantly higher proportions, in dependence of type of studied population. Malnutrition was found to be connected with prolonged hospital stay, increased rate of hospitalizations, readmissions, increased prevalence of treatment-related complications, increased prevalence of hospital infections, and mortality. [3] [4] [5] Disease-related malnutrition increases significantly the costs of treatment. 6 Main pathophysiologic issues of increased nutritional risk include changes in appetite and dietary intake, development of catabolism, manifested through loss of proteins, immunoglobulins, muscle tissue, adipose tissue, and eventually leads even to bone loss. Due to these complex reasons, functional changes develop, which are seen as changes in muscle strength and impairment of physical performance, where the latter is significantly different between the genders, in addition to age-based effects. [7] [8] [9] Disease-related unintentional loss of weight or one occurring during the course of treatment is the most important parameter of health-related malnutrition. Beside the absolute extent of the unintentional loss of weight of at least 5%, the timeline of wasting process within 6 to 12 months is of pivotal importance. 10 Cachexia represents clinical condition with significant weight loss defined primarily by reduction in skeletal muscle mass to an amount that is 2 standard deviations below gender-specific normal values for young adults. Unlike cachexia, sarcopenia represents loss of muscle tissue but does not require the presence of weight loss. Whereas most people with cachexia are sarcopenic, most sarcopenic individuals are not considered cachectic. Muscle loss without the loss or fat gaining is known as sarcopenic obesity. 11, 12 Sarcopenia is commonly prevalent in elderly population and is associated with increased mortality. 13, 14 A recent retrospective study of elderly patients showed that the prevalence of sarcopenia in the general population ranged from 12.6% (Poland) to 17.5% (India) and that of sarcopenic obesity ranged from 1.3% (India) to 11.0% (Spain). 15 Recent studies also showed that sarcopenia increases the risk for cardiovascular diseases in non-obese men 16 and is also independently associated with insulin resistance, increased risk of nonalcoholic fatty liver disease, and hypertension and arterial stiffness. [17] [18] [19] [20] Co-existing sarcopenia and obesity (sarcopenic obesity) further increase the risk of morbidity and mortality, especially in male subjects in whom sarcopenic obesity is associated with a 24% increased risk of all-cause mortality. 21 
Clinical Assessment of Nutritional Risk
In general, clinical assessment of nutritional risk is a complex task, with no highly specific test available. The most convenient tool for identifying nutritional risk is using complex screening tools, made up from several sets of clinical data, which commonly include the extent and timeline of unintentional loss of 22 This screening tool was tested in multicenter randomized settings and was shown to be of high sensitivity and specificity for detection of malnutrition. Furthermore, it was shown to be reproducible for frequent repeated re-testing and closely connected with clinical endpoints such as rate of readmissions, duration of hospitalization, complications rate, treatment costs, and mortality. 23 The NRS-2002 is one of the most widely used tools for screening of malnutrition in hospitalized or institutionalized patients. 23, 24 NRS-2002 is made up from summation of up to 3 points for disease severity, up to 3 points for degree of unintentional loss of weight, and 1 point in case patient is more than 70 years of age. 24 NRS-2002 being equal or greater than 3 points is regarded as increased nutritional risk.
One must also mention that there are numerous other screening tools existing, which as well could be used in clinical settings like the Malnutrition Universal Screening Tool (MUST), 25, 26 Nutrition Risk Index (NRI), 27 nutrition risk score, 27 subjective global assessment (SGA), 28 and mini nutritional assessment. 29 Various anthropometric methods are easy available, widely used, and could be considered as the cornerstone for assessment of nutritional status. 30 Conventional measurements in terms of body mass index (BMI) or waist-to-hip ratio were identified as important parameters for detection of malnutrition and on the other side being closely connected with clinically relevant endpoints in numerous studies. [31] [32] [33] Bioelectrical impedance analyses were shown to be solidly connected with nutritional status, however, of controversial connects with composited prognostic endpoints. 34 Assessment of body composition is made using skinfold caliper, a convenient tool with solid accuracy. 35, 36 The dual-energy X-ray absorptiometry (DEXA) scan as well as other imaging modalities like ultrasound, computerized tomography, or magnetic resonance have the utility of highly precise estimation of lean body mass, adipose tissue share, and offer other relevant information on body composition. [37] [38] [39] Muscle function tests like hand grip offer valuable information on nutritional status and mortality. 40, 41 There is still no availability of highly specific laboratory test for detection of malnutrition, particularly in terms of connection with clinically relevant prognostic outcomes. Nevertheless, several tests can point toward malnutrition like B 12 and D-vitamin status. 42, 43 Albumin is a parameter that is frequently discussed in connection with nutritional status. It is however closely related to worse prognostic outcomes in numerous health conditions; the long half-life (20 days) of plasma is not very sensitive for the detection of malnutrition or fine-tuned day-to-day changes in nutritional status. 44 The calorimetric assessment of nutritional status is complex and difficult to perform in large case series of patients; due to variable accuracy regarding numerous external factors and complicated diagnostic machinery, it is not widely available as a clinical tool for the detection of malnutrition. 45, 46 The assessment of nutritional status, and taking notion of metabolic disturbances that occurred due to severe illness or major invasive treatment, is commonly overlooked in routine clinical practice, in contrast to both guidelines of the American and European society for enteral and parenteral nutrition which based on clinical evidence unanimously agreed on absolute necessity to detect malnutrition in any medical contact point. 24, 47, 48 
Nutritional Risk and Cardiovascular Risk Factors and Comorbidities
Cardiovascular diseases (CVDs) are among the most important public health burden worldwide. 49 They are the very common chronic comorbidities, and ischemic heart disease being the first cause of death in most of the developed nations, as well as in great part of developing world. 50 There are numerous chronic risk factors that are related to development or more severe course of the CVDs and nutritional risk as well. 40, 51 Most of the disease scoring systems in cardiology include those factors as well. In particular, the most commonly used risk scoring systems like congestive heart failure, hypertension, age, diabetes mellitus, stroke or transitory ischemic atack, vascular disease; sex categorie (CHADS-VASCII), thrombolysis in acute myocardial infarction (TIMI) score, Syntax II score, surgical Euroscore II, and 10-year Systemic Coronary Risk Estimation (SCORE) include age of patient, prevalence of hypertension, dyslipidemia, chronic renal disease or diabetes mellitus, and chronic obstructive pulmonary disease, which are at the same time disease severity cofounders for NRS-2002. 51, 52 Severe acutization of cardiac condition on a perplexed ground of several chronic risk factors can indeed become life-threatening situation, with development of catabolism and significant increase to the nutritional risk as well. In addition, disease severity parameter could also be significantly enhanced by highly invasive treatment as cardiac surgery or critically ill patients on cardiac intensive care units (ICUs) who have cardiac or multiple organ failure, systemic infections, using mechanic ventilation, extracorporeal membrane oxygenation, mechanic circularity support, dialysis, or others. 53, 54 On the other hand, in most of the disease entities from the cardiovascular disease continuum observed better survival of obese patients when compared with their peers of normal weight in terms of the obesity paradox, which could be, in part, explained through the confounding effects of lesser nutritional risk in the obese patients. 55 
Nutritional Risk and Pharmacotherapy
Medications have the potential to affect nutritional status in many different ways. A large number of drugs are potentially associated with negative effect on nutrition status through 3 alterations in taste, intestinal absorption, metabolism, etc. Recent review on nutrition places polypharmacy as one of the crucial determinants of disease-related malnutrition (DRM). 56 Drug interactions with food can be of mechanical origin due to altered absorption, gastrointestinal transport, and metabolism, or due to systemic distribution, liver metabolism, and (liver or renal) excretion. 57 Moreover, several populations have greater risk of drug-nutrient interactions: undernourished, those with severe chronic multimorbidity, children, and pregnant women. 57, 58 The causes of most clinically significant drugnutrient interactions are usually multifactorial; therefore, failure to identify and properly manage these interactions can lead to very serious adverse events with negative impact on clinical outcomes. 58 Cardiovascular patients often require prescription of several medications to slow down disease progression and to control different symptoms. Despite the fact that the use of multiple drugs can be very important in the treatment, it can increase the risk of potential "drug-drug" and/or "drug-nutrient" interactions. 57, 59 Even therapy with single drug can be associated with nutrition issues and adverse reactions. 60 It is well known that diuretics can cause electrolyte imbalance, and in the context of CVDs, the greatest concern are hypokalemia and hypomagnesemia associated with increased frequency of malignant arrhythmias and sudden cardiac death. 61, 62 Furthermore, thiazides are frequently associated with severe hyponatremia, especially in older patients. [63] [64] [65] Angiotensin-converting enzyme (ACE) inhibitors usually raise concern because of the potential to cause hyperkalemia, but according to studies, it is safe to use new-generation ACE inhibitors in patients with normal renal function without worrying about potential hyperkalemia. 66, 67 Hyperkalemia can also be caused by aldosterone antagonists, beta-blockers, and potassium supplements which are the mainstay in heart disease treatment, especially optimal medical therapy for heart failure (HF). 68 When talking about nutritional risk, the protective role of ACE inhibitors now becomes a well-known fact. The mechanism of ACE inhibitors action on the prevention of cardiac cachexia is not fully clarified, but it could be related to modification of the neurohormonal axis and decrease in circulating catecholamines and inflammatory cytokines such as tumor necrosis factor (TNF)-α and interleukin 6. 69-72 Similar beneficial effects have been shown with beta-blockers. [73] [74] [75] Maximal tolerated dosages of ACE inhibitors or beta-blockers in patients with HF are first-line strategy for preventing sarcopenia and malnutrition; however, it is difficult to recommend other pharmacological agents as part of routine treatment. 75 On the other hand, according to review articles, few antihypertensive agents, including angiotensin receptor blockers (ARB), ACE inhibitors, and potassium-sparing as well as thiazide diuretics, have been associated with lower levels of zinc, which can lead to dysgeusia and anorexia and also worsen wound healing. 56 Despite the fact that proton pump inhibitors (PPIs) are not drugs for the treatment of CVD, they are often prescribed in these patients, especially in elderly and are significantly associated with parameters of NRS. 76 According to some studies, 25% to 86% of elderly patients have been overprescribed with PPIs, mostly because of the antiaggregation therapy commonly used by cardiovascular patients. [76] [77] [78] In addition, in cardiovascular patients, PPIs seem to be negatively connected with nutritional risk, mostly due to increase in gastric malabsorption and anemia. 76 While, as mentioned above, ACE inhibitors may have protective role on nutritional risk, PPIs and loop diuretics might be associated with increased nutritional risk and unintentional weight loss. 79 
Nutritional Risk and Cardiac Surgery
Malnutrition is prevalent in cardiac surgery. Malnutrition risk factors comprise 3 different clinical groups: psychosocial and lifestyle factors, laboratory findings, and disease-related factors. Patients who are most likely to be malnourished are those who have decreased mobility and food intake with valve pathology, severe systolic dysfunction, chronic renal dysfunction, and high inflammatory markers. 80, 81 Disease-related malnutrition is a serious problem for patients undergoing cardiac surgery because it not only results in higher risk of postoperative infections and other complications but also prolongs hospital stay and consequently higher mortality rates. [82] [83] [84] Due to these undesirable outcomes, early recognition of patients with suboptimal nutritional status in perioperative time is of pivotal importance to assure optimal nutritional assessment and interventions. 85, 86 Despite the existence of numerous tools for assessing nutritional risk, such as Nutritional Risk Screening tool in 2002 (NRS 2002), MUST, NRI, and others mentioned earlier, there was a need for a more specific tool for assessing nutritive risk before cardiac surgery. For that purpose, tools like Cardiac SurgerySpecific Malnutrition Universal Screening Tool (CSSM) and Cardiac Surgery-Specific Undernutrition Screening Tool (CSSUST) were created. 87, 88 CSSUST proved to be superior to other tools in identifying poor nutritional status in patients undergoing cardiac surgery and is clinically widely accepted. 88 Cardiac surgery patients with a prolonged ICU stay (>5 days) may benefit most from early nutrition support. 81, 89, 90 Stoppe et al 90 proved in a prospective trial that combined use of different clinical scores including nutrition risk screening tool (NRS 2002) helps in prediction of prolonged ICU stay in these patients which could help to identify those who will benefit the most of early postoperative nutrition therapy.
Several studies implied that high dietary intakes of saturated fatty acids and cholesterol in candidates for coronary artery bypass graft (CABG) surgery were related to low serum albumin and high HbA1C concentration which is associated with worsening of chronic kidney disease, prolonged wound healing, and consequently higher short-and long-term mortality. 91, 92 Obesity is widely accepted to complicate anesthesia and surgery, being a risk factor for mediastinitis after CABG. 93, 94 Patients with morbid grade obesity undergoing CABG and underweight patients slightly more than morbidly obese suffer increased crude mortality. 94, 95 Despite many patients undergoing cardiac surgery being overweight and obese, significant proportion display clinical signs of malnutrition. 96 This implies the need for regular assessment of nutritional status and appetite which should be conducted regularly as well as interventions to improve nutritional status should be started preoperatively and be more aggresive. [94] [95] [96] In the CoCoS trial, the investigators aimed to assess whether nutrition therapy could alter caloric deficit, morbidity, and mortality in patients scheduled for non-emergency CABG or aortic valve surgery. Results suggested that nutrition therapy deserves to be implemented as a standard-of-care supportive therapy in these patients. 97 
NRS in Ischemic Heart Disease
Traditional risk factors for endothelial dysfunction (age, gender, total cholesterol, high-density lipoprotein cholesterol, arterial hypertension, and smoking) are included in scores for evaluation of the 10-year cardiovascular risk in everyday clinical practice (eg, Framingham score and SCORE). Nonetheless, pro-inflammatory mediators are deeply involved in the initiation and the progression of coronary artery disease (CAD) and can act independently of metabolic risk factors. 98 Back in the late 1980s, 2 prospective trials were performed in male population with prophylactic aims including nutritional interventions in a group of high CVD risk: lowering of the total caloric intake, consumption of food cholesterol and refined sugar, as well as rise of animal protein, poly-unsaturated fatty acid (PUFA) and monounsaturated fatty acid (MUFA), and complex carbohydrates consumption. After 3 years of follow-up, these interventions resulted in reduction of risk factors for coronary disease, mostly on the drop of blood plasma cholesterol and the decrease of arterial pressure provided by weight reduction. 99, 100 On the other hand, increased consumption of refined carbohydrates and alcohol consumption enhanced the impact of common risk factors (eg, overweight, arterial hypertension, and dyslipidemia) on CVD development. 100 Several trials proved that patients with CVD tend to delay lifestyle modification until symptoms occur. 101 Despite the knowledge of hyperlipidemia and obesity as significant risk factors in coronary heart disease (CHD), attention to healthy nutrition significantly decreases over time in patients who have undergone CABG. 102 Thus, patients who have undergone CABG, especially male patients >50 years old would benefit from supplementary nutrition counseling education. 102 Moreover, counseling based on different models seems to be effective in improving nutritional knowledge and most importantly nutritional behavior, which could improve long-term outcomes in cardiac surgery patients through controlling cardiovascular risk factors: for example, reducing blood pressure through low salt diet and lowering blood cholesterol through Mediterranean diet. [103] [104] [105] In addition, nutrition is a modifiable risk factor for systemic inflammation which ensues CHD, and its optimization may reduce post-cardiac surgery mortality, atrial fibrillation, and cognitive decline. 106 Dutch group showed that share of patients with CHD undergoing surgery with dietary intakes below recommendations were 62% for fruits, 87% for vegetables, 73% for dietary fiber, 98% for vitamin D, as well as patients with dietary intakes above recommendations were 95% for saturated fat. Unbalanced pre-operative diets put them at risk of unfavorable surgical outcomes, because they promote a pro-inflammatory state. 106 Undesirable changes in nutrition happens after CABG surgery with increase in fat consumption which occurred despite the provision of dietary advice and highlights the need to understand better the barriers to nutritional advices and education. 106, 107 There have been a number of studies proving the prognostic effects of poor nutritional status and cardiac cachexia on CAD. However, no nutritional index has been firmly established yet in patients with CAD. 108, 109 The Prognostic Nutritional Index (PNI) is a well-accepted nutritional status parameter in patients with cancer and those undergoing gastrointestinal surgery, and lower PNI was associated with worse long-term cardiovascular outcomes in patients with stable CAD. 109 Also, previous studies have reported the prognostic value of objective nutritional indices such as the Controlling Nutritional Status (CONUT) score, Geriatric Nutritional Risk Index (GNRI), and PNI. 109, 110 The Combined Objective Nutritional Score comprised high CONUT score, low GNRI, and low PNI, and patients with a Combined Objective Nutritional Score of 3 showed 3-fold increases in risk of mortality and 2-fold increase in cardiac mortality compared with patients with score of 0. 110 Doi et al 108 introduced TCBI (Triglycerides [TG] × Total Cholesterol (TC) × Body Weight (BW) Index) in clinical usage in patients with CAD who underwent percutaneous coronary intervention (PCI), as a novel and easy to calculate nutrition index which proved to be useful prognostic indicator. Another score, Controlling Nutritional Status (CONUT; range 0-12, higher = worse, consisting of serum albumin, cholesterol, and lymphocytes), is commonly used in patients with CAD. Patients with high CONUT scores had higher rates of major adverse cardiovascular events (MACE) and pre-PCI assessment of the CONUT score may provide useful prognostic information. 111 Moreover, the combination of CONUT score and BMI was a even more useful predictor of MACE in CAD population: high CONUT score + normal BMI showed a 2.72-fold increase in the incidence of MACE compared with low CONUT score + normal BMI. 112 Geriatric nutritional risk index <92 is associated with 7-fold and 3-fold increase in the incidences of cardiac death or non-fatal myocardial infarction compared with GNRI >98. 113 Beside general malnutrition, deficit of some specific nutrients and some specific malnourishment can influence different CAD risk factors producing CAD advancement and MACE, for example, folic acid and vitamin B 12 deficiency causes hyperhomocysteinemia leading to acute myocardial infarction. 114 In addition, You et al 115 proved that pre-procedural prealbumin levels ⩽185.5 mg/L were significantly associated with contrast-induced acute kidney injury in geriatric patients undergoing elective PCI and consequently with increase in long-term mortality.
On the contrary, despite strong association between body weight and mortality in the general population, clinical evidence suggests better outcome of overweight or obese patients with established CAD. This inverse association between obesity and CVD prognosis has been termed "obesity paradox," but its existence remains a point of debate because it is mostly observed when BMI is used to define obesity. 116, 117 According to ESPEN guidelines on definitions and terminology of clinical nutrition, chronic DRM is commonly described in patients with chronic HF defining it as nonintentional and non-edematous weight loss >7.5% of the premorbid normal weight. 1 Patients with terminal HF are the most complex population with multiple comorbidities and multiple organ dysfunction affecting appetite, intestinal absorption, aerobic metabolism, immunocompetency, neurohormonal axis, as well as protein and enzyme production at cell level. 69, 72, 118 Whether alone or in combination, micronutrient supplementation improves outcomes of patients with HF by ameliorating symptoms, work capacity, and left ventricular ejection fraction, thus increasing the quality of life. 119 As expected, malnourished patients with HF who received heart transplantation had a significantly higher incidence of posttransplantation complications (infection, late weaning from mechanical ventilation, stroke) as well as longer postoperative intensive care stay and higher mortality. 120 Similar results have been proven in patients who are candidates for continuous flow left ventricular assist device (LVAD) therapy. 121 Hospitalized patients with advanced HF are at high risk of malnutrition and death, and the Nutritional Risk Index (NRI) is a simple, wellvalidated tool for identifying patients at risk of nutritionrelated complications. 122 Advanced HF is frequently associated with severe muscle wasting, termed as cardiac cachexia, which significantly decreases the quality of life and survival in this population. 123, 124 
Nutritional Risk in Heart Failure and Cardiac Cachexia
Chronic HF has prevalence of 1% in general population. 125 Due to its symptoms, it has profound effects on the quality of life; it is common reason for hospitalizations and greater overall mortality than numerous cancers like breast or colon cancer. 125 Patients with impairment of systolic function were shown to have higher prevalence of increased nutritional risk than controls, although patients with HF and preserved systolic function eventually develop tissue wasting as well. 126 Complex perplexed mechanisms of neurohumoral, inflammatory processes with lower perfusion of multiple organs drive the chronic state of catabolism that ends up with cardiac cachexia. 127 Patients with HF who develop tissue wasting and cardiac cachexia have much higher mortality rate than their peers without cachexia. 128, 129 Cachexia as systemic tissue wasting syndrome in HF could be found in 10% to 15% of patients and it continues to progress in extent as disease severity rises. 130 Even the subtle changes in body composition, such as loss of muscle tissue in lower limbs, could be found in nearly half of patients with New York Heart Association (NYHA) grade II-IV. 127 Even the decrease of cardiac muscle tissue could be found on conventional transthoracic echocardiography. 131 It is noteworthy to mention that this inconspicuous muscle loss happens while the overall loss of weight still did not develop, and it precedes clinically overt cachexia and that it is prognostically relevant for patients. 132 Therapeutic interventions for cardiac cachexia in HF include physical training and pharmaceuticals like testosterone, growth hormone, ghrelin, supplementation of iron, and enteral substitution of essential nutrients. [132] [133] [134] 
Nutritional Risk in Cardiovascular Rehabilitation
Despite many advances in acute management of patients with CVD, secondary prevention still remains essential and should necessarily include cardiac rehabilitation (CR). 135 According to the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association (AHA), CR is a comprehensive multidisciplinary program individually tailored to the needs of patients with CVD to slow down or reverse the CVD process. 136 The core components of CR are patient assessment, nutritional counseling, optimization of drug therapy, and weight management. 136 Increased nutritional risk is common in patients starting rehabilitation after cardiac surgery and it is usually related to severity of underlying disease, age group, and renal function. Recognizing nutritional risk by routine application of nutritional risk scores improves patient evaluation. 53, 137 Suboptimal nutrition status before cardiovascular surgery has been related not only to increased morbidity and prolonged hospital stay but also to delay of postoperative rehabilitation. 135, 138 According to Arai et al, 139 who classified patients in 2 groups according to GNRI, patients in good nutrition group had earlier progression to walking after postoperative rehabilitation, higher rate of discharge home, and shorter postoperative hospitalization.
Screening patients scheduled for cardiovascular rehabilitation after treatment of ischemic or valvular heart disease (using NRS-2002 tool) revealed that more invasive treatments lead to greater nutritional risk due to increased metabolic demands, 6 Nutrition and Metabolic Insights stress, tissue damage or healing, infections, and inflammatory reaction. Also, greater weight loss was associated with surgery when compared with conservative treatments or PCI. 137 Poorer nutritional risk in patients with CVD scheduled for CR can also be related to overuse of PPI and consequent malabsorption and anemia. 76 
Treatment of Nutritional Risk
Considering the fact that malnutrition exists in patients with different types of CVD, it is common and significant risk factor associated with worse clinical outcome. Thus, it is very important not to neglect the nutritional risk and its factors. [140] [141] [142] CoCos trial, as a first randomized prospective trial on nutritional risk, proved useful in nutritional treatment in patients undergoing cardiac surgery. 97 Furthermore, nutrition treatment deserves to be implemented as primary treatment of CVD diseases. 97 In addition to cardioprotective drugs that are an integral part of CVD therapy and which have a positive nutritional effect (eg, ACE inhibitors), care should be taken on drug-nutrition interactions, especially in patients with poly-therapy. Also, one should be aware of the negative influences of some drugs, especially diuretics, and to keep their dosage as low as possible. Very important is patients' CR and their mobility, which prevents significantly muscle wasting and cachexia. It is also very important to invest efforts and resources in educating not only patients and their families but also medical personnel on nutritional risks. This leads to a better nutritional behavior and consumption of healthy diet which helps to better risk factor control (hypertension, dyslipidemia). All aforementioned is important in primary CVD prevention, but especially in secondary prevention. Also, by controlling large and well-known risk factors through dietary nutrition and physical activity, we can control the nutritional risk factors we initially were not aware of and significantly contribute to better survival and better quality of life.
In the end, it is important to stress the lack of prospective, randomized, controlled trials on nutritional risk and moreover on nutritional treatment and interventions to improve nutritional status and prevent sarcopenia and cardiac cachexia, especially in patients with prolonged ICU stay. This results in no guidelines on nutritional risk treatment in patients with CVD and chronic diseases in general, except those undergoing thoracic surgery (ESPEN guidelines). 1 However, although many clinicians are not aware of nutritional treatment importance, these interventions have high cost-benefit potential and are mostly easy to implement in everyday clinical work.
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